Komori
Medical Ikkou Group (3353) · PolicyReframed

Verification of the Purpose of Strategic Shareholdings and Decisions on Sales and Reductions

First written in FY2021. 2 of 4 entries say "Restated". Latest entry: FY2026.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2021 – FY20252021: 120212022: 020222023: 120232024: 020242025: 120252026: 12026
Same theme, other companies
Reviewing the Rationale for Cross-ShareholdingsA theme 1246 companies write about · 1 as a headwind · 663 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1250 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026ReframedAnnual report

    「The Hyakugo Bank,Ltd. 330,000 561,000 Fiscal year ending February 2026 Held to maintain and strengthen smooth financial business relationships, but following a review of the benefits of the holding, the purpose was changed to investment purposes. During the current consolidated fiscal year, 370,000 shares were sold.」

    The purpose of the holding of shares in The Hyakugo Bank,Ltd., which had been held for strategic purposes, was changed to investment purposes following a review of the benefits of the holding, and 370,000 shares were sold during the current fiscal year. The process for deciding whether to continue holding or sell shares has been made more specific.
  2. FY2025RestatedAnnual report

    「The Group holds shares in issuers that enhance its corporate value through business alliances relating to its businesses and the maintenance and strengthening of relationships with business partners. The Group’s Board of Directors verifies the appropriateness of the purpose of each holding and decides whether to continue holding the shares or reduce the holding through a sale or other means.」

    The company continues to hold strategic shareholdings for the purpose of maintaining and strengthening business relationships, with the Board of Directors deciding whether to continue holding, sell or reduce the holdings after verifying their purpose.
  3. FY2023RestatedAnnual report

    「The company holds shares in issuers that enhance its corporate value through business alliances relating to its businesses and the maintenance and strengthening of relationships with business partners. The Board of Directors verifies the appropriateness of the purpose of each holding and decides whether to continue holding the shares or reduce the holding through a sale or other means.」

    The company continues to hold strategic shareholdings for the purpose of maintaining and strengthening business relationships, with the Board of Directors deciding whether to continue holding, sell or reduce the holdings after verifying their purpose.
  4. FY2021First statedAnnual report

    「The company holds shares in issuers that enhance its corporate value through business alliances relating to its businesses and the maintenance and strengthening of relationships with business partners. The Board of Directors verifies the appropriateness of the purpose of each holding and decides whether to continue holding the shares or reduce the holding through a sale or other means.」

    The company has explicitly stated for the first time its policy of holding shares to maintain and strengthen business relationships, verifying the purpose of the holdings at Board of Directors meetings, and deciding whether to continue holding, sell or reduce the holdings.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Medical Ikkou Group yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Verification of the Purpose of Strategic Shareholdings and Decisions on Sales and Reductions | Medical Ikkou Group Co.,Ltd. (3353) | Komori